MARC record from Internet Archive

LEADER: 04658cam 22006854a 4500
001 ocn739913830
003 OCoLC
005 20180518014158.0
008 110706s2012 miu b 001 0 eng
010 $a 2011023749
040 $aDLC$beng$cDLC$dYDX$dYDXCP$dVFY$dVFC$dKUT$dPIT$dHAC$dIOE$dQBX$dILC$dBDX$dVP@$dSTF$dOCLCQ$dE5G$dOCLCA$dOCLCF$dOVY$dOCLCQ$dGBVCP$dTDS$dOCLCO$dMMV$dG3T$dCHILD
019 $a793852771
020 $a9780737757538$q(hardback)
020 $a0737757531$q(hardback)
020 $a9780737757545$q(pbk.)
020 $a073775754X$q(pbk.)
035 $a(OCoLC)739913830$z(OCoLC)793852771
042 $apcc
043 $an-us---
050 00 $aRM301.15$b.P477 2012
082 00 $a338.4/76151$223
084 $aJNF053000$2bisacsh
245 04 $aThe pharmaceutical industry /$cRoman Espejo, book editor.
260 $aFarmington Hills, MI :$bGreenhaven Press,$c℗♭2012.
300 $a189 pages ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aOpposing viewpoints series
520 $a"The Pharmaceutical Industry: Is Pharmaceutical Research Safe and Unbiased?; Are Prescription Drugs Appropriately Regulated?; Are Pharmaceutical Marketing Practices Ethical?; Is the Cost of Prescription Drugs in America Appropriate?"--Provided by publisher.
504 $aIncludes bibliographical references and index.
520 $aPresents essays with opposing viewpoints on problems of drug testing, safety, regulation, and cost.
505 00 $gCh. 1 Is pharmaceutical research safe and unbiased? :$tPharmaceutical clinical trials save lives /$rLeslie Brody --$tPharmaceutical clinical trials imperil lives /$rCarl Elliot --$tDrug industry-sponsored research is biased /$rMarcia Angell --$tResearch without drug industry sponsorship may not be feasible /$rCaroline McGeough ;$gCh. 2 Does the FDA effectively regulate prescription drugs? :$tFDA regulation ensures drug safety and effectiveness /$rJanet Woodcock,$gas told to the$rFDA --$tFDA regulation delays the approval of beneficial drugs /$rTomas J. Philipson,$rEric Sun --$tThe FDA should allow pharmacists to dispense behind-the-counter drugs /$rRebecca Burkholder --$tThe FDA should not allow pharmacists to dispense behind-the-counter drugs /$rSidney M. Wolfe --$gCh. 3 Are pharmaceutical marketing practices adequately regulated? :$tPharmaceutical marketing practices are strictly regulated /$rJohn Patrick Oroho,$rChristine N. Bradshaw,$rChristopher R. Corallo --$tAggressive pharmaceutical marketing practices often outpace regulatory efforts /$rSusan Heavey,$rLisa Richwine --$tPharmaceutical companies unfairly influence doctors with gifts /$rSteven P. Higgins --$tMost pharmaceutical companies have legitimate relationships with doctors /$rBradley P. Knight --$gCh. 4 Is the cost of prescription drugs in America appropriate? :$tThe cost of prescription drugs is appropriate /$rCharles L. Hooper --$tThe high cost of prescription drugs forces people to buy online from risky foreign pharmacies /$rPRWeb Newswire --$tThe cost of specialty prescription drugs is too high /$rCarol M. Ostrom --$tGeneric drugs reduce the cost of prescriptions /$rLori Chordas.
650 0 $aDrugs$xResearch$vPopular works.
650 0 $aPharmaceutical industry$vPopular works.
650 1 $aDrugs$xResearch.
650 1 $aPharmaceutical industry.
650 7 $aJUVENILE NONFICTION$xSocial Issues$xGeneral (see also headings under Family)$2bisacsh
650 7 $aDrugs$xResearch.$2fast$0(OCoLC)fst00898894
650 7 $aPharmaceutical industry.$2fast$0(OCoLC)fst01060129
650 7 $aPharmazeutische Industrie$2gnd
650 7 $aArzneimittelforschung$2gnd
650 7 $aPharmaceutical industry.$2sears
650 7 $aDrugs$xResearch.$2sears
650 7 $aJUVENILE NONFICTION / Social Issues / General (see also headings under Family).$2sears
655 7 $aPopular works.$2fast$0(OCoLC)fst01423846
655 7 $aYoung adult literature.$2lcgft
700 1 $aEspejo, Roman,$d1977-
830 0 $aOpposing viewpoints series (Unnumbered)
856 4 $3Cover image$uhttps://covers.openlibrary.org/b/id/7070604-M.jpg$xOpen Library 20160725
938 $aChildren's Plus, Inc.$bCHIL$n1635788
938 $aChildren's Plus, Inc.$bCHIL$n1635897
938 $aBrodart$bBROD$n12998869$c$28.90
938 $aQuality Books, Inc.$bQUAL$na 11023749
938 $aYBP Library Services$bYANK$n7201129
938 $aYBP Library Services$bYANK$n7201131
029 1 $aAU@$b000048108185
029 1 $aGBVCP$b664063349
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 527 OTHER HOLDINGS